Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.
Martino B, Mammì C, Labate C, Rodi S, Ielo D, Priolo M, Postorino M, Tripepi G, Ronco F, Laganà C, Musolino C, Greco M, La Nasa G, Caocci G.
Martino B, et al. Among authors: lagana c.
Exp Hematol. 2017 Nov;55:71-75. doi: 10.1016/j.exphem.2017.07.007. Epub 2017 Jul 28.
Exp Hematol. 2017.
PMID: 28757432
Free article.